Apotex yesterday issued a voluntary recall of one lot of fluticasone propionate allergy nasal spray devices, noting that they may contain small glass particles. The company first discovered the issue thanks to a customer complaint. The glass particles could block the device’s actuator, according to Apotex, and impact the pump’s functionality. Get the full story at […]
Respiratory
Propeller raises $20m and prepares to extend reach beyond digital inhalers
Digital therapeutics company Propeller Health and drug-delivery device-maker Aptar Pharma are teaming up, yet again, to develop an array of connected drug-delivery devices. The pair has worked together in the past – in 2016, the companies launched the world’s first fully-integrated connected metered dose inhaler. Get the full story at our sister site, Drug Delivery Business News.
Adherium looks to give doctors a window into their patients’ lives
To control an asthma patient’s symptoms, doctors will prescribe an inhaler to stop symptoms from cropping up and a rescue inhaler to be used if patients find themselves in the middle of an asthma attack. “But if your rescue inhaler doesn’t give you the relief that you need, your next recourse is to go to […]
Pulmonx touts quality of life, lung function improvements in 1-year Zephyr endobronchial valve IDE study
Pulmonx yesterday released one-year results from the pivotal trial of its Zephyr endobronchial valve designed to treat patients with severe emphysema from chronic obstructive pulmonary disease, touting significant improvements in lung function and quality of life. Results from the study were presented at the American Thoracic Society 2018 international conference and published in the American Journal […]
GSK’s Arnuity Ellipta asthma therapy wins FDA nod for use in kids as young as 5 years old
GlaxoSmithKline (NYSE:GSK) won FDA approval for the use of its Arnuity Ellipta inhaler as a once-daily therapy for the maintenance treatment of asthma in children as young as five years old. The pharmaceutical company touted its regulatory win, pointing out that the fluticasone furoate treatment is one of the only once-daily asthma therapies cleared in the […]
ResMed touts cost efficiency in home oxygen, non-invasive ventilation therapy study
ResMed (NYSE:RMD) today released data from two clinical analyses exploring combined home oxygen therapy and non-invasive ventilation therapy for patients with persistent hypercapnia following a life-threatening exacerbation of chronic obstructive pulmonary disorder, touting an increase in cost efficiency with the combined therapy. Results from the two studies, performed in the U.K. and the US, were presented […]
GlaxoSmithKline touts long-term study of biologic treatment for severe eosinophilic asthma
GlaxoSmithKline (NYSE:GSK) touted new data today from a long-term study of its biologic treatment for patients with severe eosinophilic asthma. One-third of patients treated with mepolizumab experienced no exacerbations, GSK reported – down from an average of two exacerbations each year at the start of the study. Get the full story at our sister site, Drug […]
Auris Health, Ethicon’s NeuWave ink robot-assisted bronchoscope ablation dev deal
Auris Health, previously known as Auris Surgical Robotics, said today it inked a cooperative development and commercialization deal with Johnson & Johnson (NYSE:JNJ) division Ethicon’s NeuWave Medical subsidiary looking to develop systems for the robotically-assisted bronchoscopic ablation of lung lesions. Through the agreement, both companies will help develop an integrated system for robotic control, navigation and […]
Inspire Medical prices up-sized $108m IPO
Inspire Medical Systems yesterday up-sized its initial public offering to $108 million, or some $124 million if the underwriters option is exercised in full. Maple Grove, Minn.-based Inspire, which spun out from Medtronic (NYSE:MDT) in 2007, makes devices for treating obstructive sleep apnea. The company had said it planned to issue 5 million shares at $14 to $16 apiece, […]
Body Vision Medical wins FDA nod for LungVision lung nav cath
Body Vision Medical said today it won FDA clearance for its LungVision lung navigation catheter. The Israel-based company said its LungVision catheter is designed for use in conjunction with standard bronchoscopes and its LungVision system for guiding endotherapy accessories to small pulmonary modules. “Body Vision has pioneered a new generation platform for navigation bronchoscopy that […]
Vyaire Medical acquires Acutronic, inks deal to acquire IMTmedical
Vyaire Medical said yesterday it acquired neonatal ventilation equipment developer Acutronic for an undisclosed amount, and said it inked a deal to acquire mechanical ventilation dev IMTmedical. Both of the new acquisitions are based in Europe, with Acutronic split between Switzerland and Germany and IMTmedical based solely in Switzerland, Chicago-based Vyaire Medical said. “The transactions […]